![]() |
SABCS15: Promising phase 1 results lead to phase 2 for ONT-380 in HER2+ breast cancer
Results of an ongoing phase 1b clinical trial presented at the 2015 San Antonio Breast Cancer Symposium show promise of the experimental anti-cancer agent ONT-380 against metastatic HER2+ breast...
More... |
| All times are GMT -7. The time now is 03:41 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021